GlucoSet wins FDA breakthrough nod for glucose biosensor tech
October 3, 2025
GlucoSet announced today on social media that it received FDA breakthrough device designation for its glucose monitoring technology.
GlucoSet announced today on social media that it received FDA breakthrough device designation for its glucose monitoring technology.
NEWPORT BEACH, Calif., Oct. 3, 2025 /PRNewswire/ — Gnosis for Her, a mobile breast health initiative redefining comfort and access in women’s breast imaging, made its national debut this past weekend at Susan G. Komen’s More Than Pink Walk at Fashion Island. More than 6,000 breast cancer survivors, loved ones, advocates, and supporters had the opportunity to see the Mobile Care Unit up close, tour inside, and speak with the expert team behind the service.
Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases (IBD), but also successfully used a new type of AI to predict exactly how the drug works. To their knowledge, this is a global first for the AI.
Trying to document how single brain cells participate in networks that govern behavior is a daunting task. Brain probes called Neuropixels, which feature high-density silicon arrays, have enabled scientists to collect electrophysiological data of this nature from a variety of animals
If you’ve been to a medical appointment recently, you may have already interacted with AI. As you describe your symptoms to the doctor, they may ask your permission to use an “AI scribe” to convert audio into medical notes in real time.
MIT CSAIL and McMaster researchers used a generative AI model to reveal how a narrow-spectrum antibiotic attacks disease-causing bacteria, speeding up a process that normally takes years.
Plexāā announced that it launched its Bloom43 wearable preconditioning medical device for breast surgery in the U.S.
IceCure Medical (Nasdaq:ICCM) announced today that the FDA granted marketing authorization for its ProSense cryoablation system for breast cancer.
Hologic’s FDA clearance for its Panther Fusion GI Bacterial and Expanded Bacterial Assays represents the company’s entry into the gastroenteritis test market.
SAN DIEGO, Oct. 1, 2025 /PRNewswire/ — A groundbreaking study published in Translational Lung Cancer Research reveals the potential of LungCanSeek, a novel blood test that uses four protein markers and artificial intelligence, to transform lung cancer screening by making early detection both highly effective and cost-efficient for broad populations, including those in low- and middle-income countries.